129 related articles for article (PubMed ID: 2107021)
1. Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix.
Sugarbaker PH; Landy D; Jaffe G; Pascal R
Cancer; 1990 Apr; 65(7):1495-501. PubMed ID: 2107021
[TBL] [Abstract][Full Text] [Related]
2. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?
Sugarbaker PH
Lancet Oncol; 2006 Jan; 7(1):69-76. PubMed ID: 16389186
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Sugarbaker PH
Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
[TBL] [Abstract][Full Text] [Related]
4. Treatment of peritoneal carcinomatosis from colon or appendiceal cancer with induction intraperitoneal chemotherapy.
Sugarbaker PH
Cancer Treat Res; 1996; 82():317-25. PubMed ID: 8849959
[TBL] [Abstract][Full Text] [Related]
5. Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin.
Zoetmulder FA; Sugarbaker PH
Eur J Cancer; 1996 Sep; 32A(10):1727-33. PubMed ID: 8983281
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal chemotherapy for peritoneal carcinomatosis from colonic or appendiceal cystadenocarcinoma: rationale and results of treatment.
Sugarbaker PH; Landy D; Pascal R
Prog Clin Biol Res; 1990; 354B():141-70. PubMed ID: 2236162
[TBL] [Abstract][Full Text] [Related]
7. Calcification of pseudomyxoma peritonei following intraperitoneal chemotherapy: CT demonstration.
Miller DL; Udelsman R; Sugarbaker PH
J Comput Assist Tomogr; 1985; 9(6):1123-4. PubMed ID: 2997312
[TBL] [Abstract][Full Text] [Related]
8. Therapy of pseudomyxoma peritonei of appendiceal origin--surgical resection and intraperitoneal chemotherapy.
Hosch WP; Rudi J; Stremmel W
Z Gastroenterol; 1999 Jul; 37(7):615-22. PubMed ID: 10458011
[TBL] [Abstract][Full Text] [Related]
9. Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei.
Bjersand K; Mahteme H; Sundström Poromaa I; Andréasson H; Graf W; Larsson R; Nygren P
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S810-6. PubMed ID: 26193962
[TBL] [Abstract][Full Text] [Related]
10. [Intraperitoneal administration of a combined CDDP, 5-FU and MMC therapy for pseudomyxoma peritonei].
Sasaki A; Terashima M; Okamoto K; Ikeda K; Takagane A; Takiyama I; Shimada Y; Yamamoto M; Nakajima J; Sasaki N; Saito K
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1828-31. PubMed ID: 10560405
[TBL] [Abstract][Full Text] [Related]
11. Delayed repeated intraperitoneal chemotherapy after cytoreductive surgery for colorectal and appendiceal carcinomatosis.
Fajardo AD; Tan B; Reddy R; Fleshman J
Dis Colon Rectum; 2012 Oct; 55(10):1044-52. PubMed ID: 22965403
[TBL] [Abstract][Full Text] [Related]
12. Management of an inguinal hernia in patients with pseudomyxoma peritonei.
Sugarbaker PH
Eur J Surg Oncol; 2017 Jun; 43(6):1083-1087. PubMed ID: 28131668
[TBL] [Abstract][Full Text] [Related]
13. An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution.
Sugarbaker PH
J Surg Oncol; 2005 Nov; 92(2):142-6. PubMed ID: 16231365
[No Abstract] [Full Text] [Related]
14. [Intraoperative (hyperthermic) intraperitoneal chemotherapy--considerations and aspects of safe intra- and postoperative treatment with cytostatic drugs].
Jähne J; Piso P; Schmoll E; Haulitschek-Hauss R; Sterzenbach H; Paul H; Pichlmayr R
Langenbecks Arch Chir; 1997; 382(1):8-14. PubMed ID: 9157234
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG
Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.
Marcotte E; Dubé P; Drolet P; Mitchell A; Frenette S; Leblanc G; Leclerc YE; Sideris L
World J Surg Oncol; 2014 Nov; 12():332. PubMed ID: 25380618
[TBL] [Abstract][Full Text] [Related]
17. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm.
Murphy EM; Sexton R; Moran BJ
Dis Colon Rectum; 2007 Jan; 50(1):37-42. PubMed ID: 17115339
[TBL] [Abstract][Full Text] [Related]
18. Inguinal canal as an anatomic sanctuary site of relapse in peritoneal carcinomatosis previously treated with intraperitoneal chemotherapy.
Liberale G; Elias D; Sideris L; Lasser P; Malka D; Sabourin JC; Pocard M
J Surg Oncol; 2005 Jul; 91(1):73-6. PubMed ID: 15999360
[TBL] [Abstract][Full Text] [Related]
19. Management of peritoneal carcinomatosis.
Sugarbaker PH
Acta Med Austriaca; 1989; 16(3-4):57-60. PubMed ID: 2514551
[TBL] [Abstract][Full Text] [Related]
20. [Two cases of pseudomyxoma peritonei that responded to intraperitoneal administrations of a combined CDDP, 5-FU and MMC therapy].
Sasaki A; Terashima M; Okamoto K; Ikeda K; Takagane A; Takiyama I; Kuboi M; Sasaki N; Saito K
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1571-4. PubMed ID: 8854808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
